
NYSE:ELAN
This summary was created by AI, based on 2 opinions in the last 12 months.
Elanco Animal Health (ELAN-N) has received positive feedback from analysts following their recent quarterly report, which showcased a strong performance across all metrics. The company achieved organic sales growth of 8%, surpassing expectations, and has revised its full-year forecast upward, indicating robust operational momentum. Experts have expressed their admiration for Elanco's effective turnaround strategy, suggesting that the company's management has successfully navigated previous challenges. This optimistic sentiment reflects confidence in Elanco's ability to sustain its growth trajectory and deliver value to its shareholders in the future. Overall, the reviews highlight a promising outlook for Elanco as it continues to strengthen its position in the animal health market.
Spun off from Eli Lilly in 2018. Reported a mixed report today, including their pet business missing as guidance for the current quarter fell short. They will sell its Aqua business to Merck Animal Health, announced restructuring/job cuts and will increase cash flow conversions four times this year, which is a priority. This gives him some hope in the name.
Elanco Animal Health is a American stock, trading under the symbol ELAN (previously ELAN-N on Stockchase) on the New York Stock Exchange (ELAN). It is usually referred to as NYSE:ELAN or ELAN
In the last year, 2 stock analysts issued a Buy, Sell, or Hold rating on ELAN (previously ELAN-N on Stockchase). 2 analysts recommended to BUY and 0 analysts recommended to SELL the stock. The latest stock analyst rating is BUY. Read the latest stock experts' ratings for Elanco Animal Health.
Elanco Animal Health was never recommended as a Top Pick on Stockchase. Read the latest stock experts ratings for Elanco Animal Health.
Earnings reports or recent company news can cause the stock price to drop. Read stock experts' recommendations for Elanco Animal Health.
Elanco Animal Health is covered by Stockchase experts and is worth watching.
On 2026-08-13, Elanco Animal Health (ELAN) stock closed at a price of $22.51.
Today, they reported a great quarter: beating every metric, organic sales +8%, and raised their full-year forecast.